Not Medicare Enrolled
Dr. Louis Valente, M.D.
Optician · Port Charlotte, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Valente from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Valente?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Valente
Dr. Louis Valente is an optician specialist in Port Charlotte, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Valente performed 9,129 Medicare services across 3,481 unique beneficiaries.
Between the years covered by Open Payments, Dr. Valente received a total of $4,343 from 37 pharmaceutical and/or device companies across 129 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Valente is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in FL
$4,343 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,129
Medicare services
Top 10% in FL for optician
3,481
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~480 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
1,779 | $0 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,343 | $62 | $263 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
987 | $0 | $2 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
793 | $5 | $13 |
| Contrast dye for imaging, lower concentration | 788 | $0 | $15 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
677 | $9 | $55 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
264 | $38 | $145 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
241 | $61 | $238 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
222 | $9 | $32 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
218 | $185 | $753 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
185 | $175 | $702 |
| Injection, methylprednisolone acetate, 40 mg | 180 | $6 | $55 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
173 | $97 | $363 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
139 | $457 | $1,759 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
134 | $255 | $950 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
129 | $178 | $687 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
120 | $93 | $352 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
95 | $148 | $589 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
70 | $54 | $216 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
65 | $332 | $1,354 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
64 | $85 | $337 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $117 | $494 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
60 | $208 | $782 |
| New patient office visit, complex (60-74 min) | 52 | $152 | $654 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
52 | $92 | $376 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
48 | $45 | $188 |
| Nerve destruction for spine-pelvis joint pain A procedure that destroys the nerves supplying the joint between the spine and pelvis to relieve pain. Imaging guidance is used to ensure accurate placement. |
39 | $353 | $1,388 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
39 | $1 | $5 |
| Knee nerve block injection with imaging guidance An injection of anesthetic and/or steroid medication into a nerve branch of the knee, performed using imaging guidance to ensure accurate placement. |
29 | $204 | $808 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
29 | $186 | $741 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
23 | $34 | $167 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
16 | $86 | $328 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
12 | $187 | $763 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,343
Total received (2018-2024)
Avg $620/year across 7 years
Top 25% in FL for optician
37
Companies
129
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,343 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$22
2023
$348
2022
$613
2021
$456
2020
$60
2019
$1,393
2018
$1,452
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,075
Nevro Corp.
$991
Medtronic USA, Inc.
$478
Relievant Medsystems, Inc.
$265
Nuvectra Corporation
$175
Allergan Inc.
$118
VGI Medical, LLC
$107
AbbVie Inc.
$101
Stimwave Technologies Incorporated
$86
Avanos Medical
$83
Allergan, Inc.
$71
Flexion Therapeutics, Inc.
$60
Boston Scientific Corporation
$58
BOSTON SCIENTIFIC CORPORATION
$57
Merit Medical Systems Inc
$53
US WorldMeds, LLC
$51
Collegium Pharmaceutical, Inc.
$45
ABBVIE INC.
$45
Nalu Medical, Inc.
$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$42
Vertiflex, Inc.
$42
Medtronic, Inc.
$33
Novartis Pharmaceuticals Corporation
$30
SANOFI-AVENTIS U.S. LLC
$29
Amgen Inc.
$20
SPR Therapeutics, Inc
$20
Shionogi Inc
$19
SI-BONE, INC.
$18
Daiichi Sankyo Inc.
$17
AstraZeneca Pharmaceuticals LP
$16
PAINTEQ LLC
$16
Almatica Pharma LLC
$15
Kowa Pharmaceuticals America, Inc.
$15
Jazz Pharmaceuticals Inc.
$15
Vertos Medical, Inc.
$13
PFIZER INC.
$11
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 58.6% of total payments
Associated products mentioned in payments ›
AJOVY · Algovita · Axium INS DRG IPG · BOTOX · BOTOX THERAPEUTIC · COOLIEF · ETERNA · Eon Family of SCS IPGs · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON Balloon Kyphoplasty · LUCEMYRA · LYRICA · MOVANTIK · MYOBLOC · Morphabond ER · Nalu Neurostimulation System · OSTEOCOOL RF ABLATION · Omnia · PAINTEQ · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · RELISTOR ORAL · SPRINT PNS System · SYNVISC-ONE · Seglentis · Senza · Senza Spinal Cord Stimulation System · SiJoin · StabiliT · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · UBRELVY · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $48 per 100 Medicare services performed
Geographic Context
Opticians within 10 mi
48
Per 100K population
24.6
County median income
$66,154
Nearest hospital
Adventhealth Port Charlotte
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Valente is a clinical cardiology specialist, with above-average Medicare volume (top 10% in FL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Valente experienced with midazolam injection, per 1 mg?
Based on Medicare claims data, Dr. Valente performed 1,779 midazolam injection, per 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Valente receive payments from pharmaceutical companies?
Yes. Dr. Valente received a total of $4,343 from 37 companies across 129 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Valente's costs compare to other opticians in Port Charlotte?
Dr. Valente's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Valente) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Port Charlotte
Browse opticians in Port Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Opticians in FL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in FL
Which FL opticians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology